Internal Medicine

Research output

Research output per year 1975 2007 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 4414 Article
• 824 Review article
• 282 Comment/debate
• 268 Letter
• 402 More
  • 152 Editorial
  • 146 Chapter
  • 50 Short survey
  • 32 Conference contribution
  • 8 Foreword/postscript
  • 8 Conference article
  • 5 Book
  • 1 Paper

Research output per year

Research output per year

Search results

• 2024

  Acute esophageal stricture after bone marrow transplant

  Pang, S., Saleh, H., Ailawadhi, S., Edgar, M. & Pang, M., Feb 2024, In: Clinical Journal of Gastroenterology. 17, 1, p. 1-5 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Stenosis 100%
  • Bone Marrow Transplantation 78%
  • Bone Marrow 56%
  • Transplants 47%
  • Triamcinolone 25%

• An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma

  Alodhaibi, I., Ailawadhi, S., Burbano, G. P., O'Brien, P. J., Buadi, F. K., Hayman, S., Kumar, S. K. & Gonsalves, W. I., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.

  Research output: Contribution to journal › Article › peer-review

  • Nelfinavir 100%
  • Bortezomib 82%
  • Metformin 72%
  • Multiple Myeloma 66%
  • Safety 10%

• A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis

  Southern, B. D., Li, H., Mao, H., Crish, J. F., Grove, L. M., Scheraga, R. G., Mansoor, S., Reinhardt, A., Abraham, S., Deshpande, G., Loui, A., Ivanov, A. I., Rosenfeld, S. S., Bresnick, A. R. & Olman, M. A., Jan 2024, In: Journal of Biological Chemistry. 300, 1, 105530.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myofibroblasts 100%
  • Disorder 74%
  • Myosin Type II 72%
  • Fibrosis 64%
  • Fibroblasts 64%

• A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma

  Beckermann, K. E., Patnaik, A., Winer, I., Tan, W., Bashir, B., Kyriakopoulos, C. E., Sweis, R. F., Chamberlain, M. & Rini, B. I., Apr 2024, In: Investigational New Drugs. 42, 2, p. 179-184 6 p.

  Research output: Contribution to journal › Article › peer-review

• A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia

  Parrondo, R. D., Dutta, N., LaPlant, B. R., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., Chanan-Khan, A. A., Paulus, A. & Ailawadhi, S., 2024, (Accepted/In press) In: British journal of haematology.

  Research output: Contribution to journal › Article › peer-review

  • ixazomib 100%
  • PCI 32765 85%
  • Waldenstrom Macroglobulinemia 78%
  • Progression-Free Survival 34%
  • Proteasome Endopeptidase Complex 19%

• Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population

  Kanj, A. N., Scanlon, P. D., Yadav, H., Smith, W. T., Herzog, T. L., Bungum, A., Poliszuk, D., Fick, E., Lee, A. S. & Niven, A. S., Jan 1 2024, In: American journal of respiratory and critical care medicine. 209, 1, p. 83-90 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients

  Ames, S. C., Lange, L., Ames, G. E., Heckman, M. G., White, L. J., Roy, V. & Foran, J. M., Feb 2024, In: Cancer medicine. 13, 3, e6906.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hematopoietic Stem Cell Transplantation 100%
  • Hematopoietic Stem Cells 92%
  • Anxiety 67%
  • Depression 61%
  • Quality of Life 60%

• A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis

  Mosalem, O., Tan, W., Bryce, A. H., Dronca, R. S., Childs, D. S., Pagliaro, L. C., Orme, J. J. & Kase, A. M., 2024, (Accepted/In press) In: Prostate Cancer and Prostatic Diseases.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • pembrolizumab 100%
  • Microsatellite Instability 87%
  • Castration 78%
  • Tumor Burden 67%
  • Prostatic Neoplasms 56%

• Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA

  Ailawadhi, S., Ravelo, A., Ng, C. D., Shah, B., Lamarre, N., Wang, R., Eakle, K. & Biondo, J. M., Feb 1 2024, In: Journal of Comparative Effectiveness Research. 13, 2, p. e230119

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • chronic lymphocytic leukemia 100%
  • Second Primary Neoplasms 58%
  • B-Cell Chronic Lymphocytic Leukemia 54%
  • Medicare Part B 11%
  • health maintenance organizations 10%

• A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML

  Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T., Li, Y., Baer, M. R., Stock, W., Kovacsovics, T., Blum, W. G., Schiller, G. J., Olin, R. L., Foran, J. M., Litzow, M., Lin, T., Patel, P., Foster, M. C., Boyiadzis, M., & 18 othersCollins, R. H., Chervin, J., Shoben, A., Vergilio, J. A., Heerema, N. A., Rosenberg, L., Chen, T. L., Yocum, A. O., Druggan, F., Marcus, S., Stefanos, M., Druker, B. J., Mims, A. S., Borate, U., Burd, A., Byrd, J. C., Levine, R. L. & Stein, E. M., Jan 23 2024, In: Blood Advances. 8, 2, p. 429-440 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • AG-221 100%
  • Isocitrate Dehydrogenase 70%
  • Azacitidine 68%
  • Acute Myeloid Leukemia 49%
  • Therapeutics 8%

• Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview

  Mercado, L. A., Gil-Lopez, F., Chirila, R. M. & Harnois, D. M., Feb 2024, In: Diagnostics. 14, 4, 382.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Azathioprine 100%
  • Autoimmune Hepatitis 77%
  • Mycophenolate Mofetil 53%
  • Adrenal Cortex Hormone 39%
  • Aspartate 33%

• Awake Craniotomy Program Implementation

  Moniz-Garcia, D., Bojaxhi, E., Borah, B. J., Dholakia, R., Kim, H., Sousa-Pinto, B., Almeida, J. P., Mendhi, M., Freeman, W. D., Sherman, W., Christel, L., Rosenfeld, S., Grewal, S. S., Middlebrooks, E. H., Sabsevitz, D., Gruenbaum, B. F., Chaichana, K. L. & Quiñones-Hinojosa, A., Jan 24 2024, In: JAMA Network Open. 7, 1, p. E2352917

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Craniotomy 100%
  • Costs and Cost Analysis 42%
  • Length of Stay 34%
  • Mortality 17%
  • Patient Readmission 13%

• Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis

  Perez-Shibayama, C., Gil-Cruz, C., Cadosch, N., Lütge, M., Cheng, H. W., De Martin, A., Frischmann, K., Joachimbauer, A., Onder, L., Papadopoulou, I., Papadopoulou, C., Ring, S., Krebs, P., Vu, V. P., Nägele, M. P., Rossi, V. A., Parianos, D., Zsilavecz, V. W., Cooper, L. T., Flammer, A., & 4 othersRuschitzka, F., Rainer, P. P., Schmidt, D. & Ludewig, B., Mar 2024, In: Nature Cardiovascular Research. 3, 3, p. 301-316 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myocarditis 100%
  • Neutralization 89%
  • Fibrosis 65%
  • Heart Failure 65%
  • Cardiac Myocytes 55%

• Circadian rhythm and whole gut transit in mice

  Laible, E., Wegner, A., Knutson, K., Kacmaz, H., Garramone, G. K., Gogineni, K., Matveyenko, A., Linden, D. R., Farrugia, G. & Beyder, A., Apr 2024, In: Neurogastroenterology and Motility. 36, 4, e14771.

  Research output: Contribution to journal › Article › peer-review

  • Circadian Rhythm 100%
  • Carmine 40%
  • Gastrointestinal Transit 22%
  • Photoperiod 20%
  • Light 16%

• Clinical and genetic predictors of cardiac dysfunction assessed by echocardiography in patients with hereditary hemochromatosis

  Cortés, P., Elsayed, A. A., Stancampiano, F. F., Barusco, F. M., Shapiro, B. P., Bi, Y., Heckman, M. G., Peng, Z., Kempaiah, P. & Palmer, W. C., Jan 2024, In: International Journal of Cardiovascular Imaging. 40, 1, p. 45-53 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Hemochromatosis 100%
  • Echocardiography 66%
  • Stroke Volume 60%
  • Mutation 44%
  • Myocardial Infarction 28%

• Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

  Li, S., Manochakian, R., Chen, R., Patel, J., Inampudi, J. V., Hiren, K. R., Zhao, Y. & Lou, Y., 2024, In: Frontiers in Oncology. 14, 1306311.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Commentary

  Kumbhari, V., Jan 30 2024, In: Endoscopy. 56, 2, p. 156 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma

  Alhaj Moustafa, M., Parrondo, R., Abdulazeez, M. F., Roy, V., Sher, T., Alegria, V. R., Warsame, R. M., Fonseca, R., Rasheed, A., Gonsalves, W. I., Kourelis, T., Kapoor, P., Buadi, F. K., Dingli, D., Hayman, S. R., Reeder, C. B., Chanan-Khan, A. A. & Ailawadhi, S., Jan 1 2024, In: Anti-cancer drugs. 35, 1, p. 63-69 7 p.

  Research output: Contribution to journal › Article › peer-review

  • daratumumab 100%
  • pomalidomide 95%
  • Lenalidomide 78%
  • Multiple Myeloma 58%
  • Dexamethasone 30%

• Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans

  Lachner, C., Craver, E. C., Babulal, G. M., Lucas, J. A., Ferman, T. J., White, R. O., Graff-Radford, N. R. & Day, G. S., Mar 2024, In: Annals of neurology. 95, 3, p. 518-529 12 p.

  Research output: Contribution to journal › Article › peer-review

  • African Americans 100%
  • Dementia 89%
  • Cognitive Dysfunction 87%
  • Confidence Intervals 36%
  • Mental Status and Dementia Tests 31%

• Early Detection of Advanced Adenomas and Colorectal Carcinoma by Serum Glycoproteome Profiling

  NICE-AA/CRC-Consortium, Jan 2024, In: Gastroenterology. 166, 1, p. 194-197.e2

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

• EDUCATE: An international, randomized controlled trial for teaching electrocardiography

  Kashou, A. H., Noseworthy, P. A., Beckman, T. J., Anavekar, N. S., Cullen, M. W., Angstman, K. B., Sandefur, B. J., Shapiro, B. P., Wiley, B. W., Kates, A. M., Sadhu, J., Thakker, P., Huneycutt, D., Braisted, A., Smith, S. W., Baranchuk, A., Grauer, K., O'Brien, K., Kaul, V., Gambhir, H. S., & 3 othersKnohl, S. J., Restrepo, D. & May, A. M., Mar 2024, In: Current Problems in Cardiology. 49, 3, 102409.

  Research output: Contribution to journal › Review article › peer-review

  • Teaching 100%
  • Electrocardiography 92%
  • Randomized Controlled Trials 76%
  • Delivery of Health Care 31%
  • Learning 30%

• Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy

  Tanabe, K. K., Zahrieh, D., Strand, C. A., Hoshida, Y., Flotte, T. J., Della'Zanna, G., Umar, A., Chavin, K. D., Cleary, S., Kubota, N., Llovet, J. M., Patel, T., Siegel, C. & Limburg, P. J., Jan 2024, In: Gastro Hep Advances. 3, 3, p. 426-439 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

  Barzi, A., Weipert, C. M., Espenschied, C. R., Raymond, V. M., Wang-Gillam, A., Nezami, M. A., Gordon, E. J., Mahadevan, D. & Mody, K., 2024, In: Frontiers in Oncology. 14, 1339302.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cell-Free Nucleic Acids 100%
  • Adenocarcinoma 62%
  • Pancreatic Neoplasms 30%
  • Therapeutics 12%
  • olaparib 12%

• Exercise After Acute Myocarditis: When and How to Return to Sports

  Bryde, R. E., Cooper, L. T., Fairweather, D. L., Di Florio, D. N. & Martinez, M. W., Mar 1 2024, In: Cardiac Electrophysiology Clinics. 16, 1, p. 107-115 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Return to Sport 100%
  • Myocarditis 87%
  • Exercise 50%
  • Lakes 32%
  • Sudden Cardiac Death 28%

• Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis

  Cooper, L. T. & Reddy, P., Jan 2024, In: JACC: Cardiovascular Imaging. 17, 1, p. 59-61 3 p.

  Research output: Contribution to journal › Editorial › peer-review

• Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

  HIMALAYA investigators, 2024, (Accepted/In press) In: Annals of Oncology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• From the Operating Room to the Laboratory: Role of the Neuroscience Tissue Biorepository in the Clinical, Translational, and Basic Science Research Pipeline

  Quiñones-Hinojosa, A., Basil, A., Moniz-Garcia, D., Suarez-Meade, P., Ramos, A., Jentoft, M., Middlebrooks, E., Grewal, S., Abode-Iyamah, K., Bydon, M., Sarkaria, J., Dickson, D., Swanson, K., Rosenfeld, S., Schiapparelli, P., Guerrero-Cazares, H., Chaichana, K. & Meyer, F., Feb 2024, In: Mayo Clinic proceedings. 99, 2, p. 229-240 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Neurosciences 100%
  • Operating Rooms 95%
  • Clinical Trials 36%
  • Cerebrospinal Fluid 32%
  • Adipose Tissue 31%

• Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms

  Baranwal, A., Basmaci, R., He, R., Viswanatha, D., Greipp, P., Murthy, H. S., Foran, J., Palmer, J., Hogan, W., Litzow, M. R., Hefazi, M., Mangaonkar, A., Shah, M. V., Al-Kali, A. & Alkhateeb, H. B., Feb 13 2024, In: Blood Advances. 8, 3, p. 562-570 9 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Geospatial analysis of cyanobacterial exposure and liver cancer in the contiguous United States

  Ledenko, M., Antwi, S. O. & Patel, T., Mar 1 2024, In: Hepatology (Baltimore, Md.). 79, 3, p. 575-588 14 p.

  Research output: Contribution to journal › Article › peer-review

• Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

  Delforge, M., Patel, K., Eliason, L., Dhanda, D., Shi, L., Guo, S., Marshall, T. S., Arnulf, B., Cavo, M., Nooka, A., Manier, S., Callander, N., Giralt, S., Einsele, H., Ailawadhi, S., Popa McKiver, M., Cook, M. & Rodríguez-Otero, P., Mar 2024, In: The Lancet Haematology. 11, 3, p. e216-e227

  Research output: Contribution to journal › Article › peer-review

  • Patient Reported Outcome Measures 100%
  • Multiple Myeloma 89%
  • Clinical Trials 59%
  • Quality of Life 58%
  • Dexamethasone 52%

• Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study

  del Valle, K. T., Krowka, M. J., Schinstock, C. A., Nath, K. A., Burger, C. D., Reddy, Y. N., Frantz, R. P., Prakash, Y. S. & DuBrock, H. M., Jan 2024, In: Pulmonary Circulation. 14, 1, e12341.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Hypertension 100%
  • Chronic Renal Insufficiency 92%
  • Nitric Oxide 81%
  • Hemodynamics 74%
  • Cohort Studies 68%

• High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction

  Knott, J. D., Ola, O., De Michieli, L., Akula, A., Yang, E. H., Gharacholou, S. M., Slusser, J., Lewis, B., Mehta, R. A., Gulati, R., Sandoval, Y. & Jaffe, A. S., 2024, (Accepted/In press) In: Mayo Clinic proceedings.

  Research output: Contribution to journal › Article › peer-review

• High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets

  Byale, A., Lennon, R. J., Byale, S., Breen-Lyles, M., Edwinson, A. L., Gupta, R., Lacy, B. E., Olson, J. E., Houghton, L. A. & Grover, M., Jan 2024, In: Clinical Gastroenterology and Hepatology. 22, 1, p. 173-184.e12

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Irritable Bowel Syndrome 100%
  • Cluster Analysis 78%
  • Comorbidity 34%
  • Constipation 30%
  • Diarrhea 24%

• Impact on Kidney Function and Medium-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease

  Naser, J. A., Luis, S. A., Pislaru, S. V., Michelena, H. I., Kennedy, A. M., Eleid, M. F., Crestanello, J. A., Chebib, F. T., Pellikka, P. A. & Nkomo, V. T., Jan 1 2024, In: American Journal of Cardiology. 210, p. 163-171 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Transcatheter Aortic Valve Replacement 100%
  • Chronic Renal Insufficiency 74%
  • Kidney 43%
  • Creatinine 26%
  • Mortality 13%

• Implementation of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education

  Vern-Gross, T. Z., Laughlin, B. S., Kough, K., Ernst, B., Langley, N., Rule, W. G., Patel, S. H. & Ashman, J. B., Feb 1 2024, In: Journal of Palliative Medicine. 27, 2, p. 231-235 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Graduate Medical Education 100%
  • Medical Oncology 89%
  • Curriculum 74%
  • Communication 56%
  • Role Playing 28%

• International Delphi Consensus Study on disposable single-use endoscopy: A path to clinical adoption

  DISPOSE Group, Feb 2024, In: Digestive and Liver Disease. 56, 2, p. 322-329 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Delphi Technique 100%
  • Critical Pathways 86%
  • Endoscopes 84%
  • Endoscopy 66%
  • Politics 18%

• Interstitial lung disease in autoimmune diseases

  Nagaraja, V., Mira-Avendano, I., Diaz-Arumir, A., Gotway, M. & Zamora, A. C., Apr 2024, In: Revista Colombiana de Reumatologia. 31, p. S139-S153

  Research output: Contribution to journal › Article › peer-review

  • Interstitial Lung Diseases 100%
  • Interstitial 95%
  • Autoimmune Diseases 78%
  • Time-to-Treatment 33%
  • Rheumatology 32%

• Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders

  Menton, S. M., Fairweather, D. L., Bruno, K. A., Thompson, C. C., Candelo, E., Darakjian, A. A., Gehin, J. M., Jain, A., Kotha, A., Whelan, E. R., Li, Z., Knight, D. R. T. & Rutt, A. L., Feb 2024, In: Laryngoscope. 134, 2, p. 773-778 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Ehlers-Danlos Syndrome 100%
  • Hoarseness 67%
  • Deglutition Disorders 36%
  • Voice Disorders 12%
  • Laryngoscopes 11%

• Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation

  Lange, L. J., Ames, S. C., Ames, G. E., Heckman, M. G., White, L. J., Roy, V. & Foran, J. M., Dec 2024, In: BMC psychology. 12, 1, 40.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Loneliness 100%
  • Hematopoietic Stem Cell Transplantation 84%
  • quality of life 63%
  • Quality of Life 50%
  • health 35%

• Lung Injury Prediction Model in Bone Marrow Transplantation: A Multicenter Cohort Study

  Herasevich, S., Schulte, P., Hogan, W., Alkhateeb, H., Zhang, Z., White, B. A., Khera, N., Roy, V., Gajic, O. & Yadav, H., Mar 1 2024, In: American journal of respiratory and critical care medicine. 209, 5, p. 543-552 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Lung Injury 100%
  • Bone Marrow Transplantation 97%
  • Multicenter Studies 82%
  • Hematopoietic Stem Cell Transplantation 67%
  • Cohort Studies 64%

• Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma

  Nadeem, O., Ailawadhi, S., Khouri, J., Williams, L., Catamero, D., Maples, K. & Berdeja, J., Mar 2024, In: Cancers. 16, 5, 1023.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

  MISEV Consortium, Feb 2024, In: Journal of Extracellular Vesicles. 13, 2, e12404.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Extracellular Vesicles 100%
  • Research Personnel 8%
  • Body Fluids 6%
  • Advisory Committees 6%
  • Terminology 6%

• Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

  Gangat, N., McCullough, K., Abdelmagid, M., Karrar, O., Powell, M., Al-Kali, A., Alkhateeb, H., Begna, K., Mangaonkar, A., Saliba, A., Torghabeh, M. H., Litzow, M., Hogan, W., Shah, M., Patnaik, M., Pardanani, A., Badar, T., Foran, J., Palmer, J., Sproat, L., & 2 othersYi, C. A. & Tefferi, A., Jan 2024, In: Haematologica. 109, 1, p. 287-292 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Myocarditis: Entering the Mainstream

  Cooper, L. T., Feb 27 2024, In: Circulation. 149, 9, p. 639-640 2 p.

  Research output: Contribution to journal › Article › peer-review

• Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis

  Sullivan, M. M., Abril, A., Aslam, N., Ball, C. T. & Berianu, F., Dec 2024, In: Arthritis Research and Therapy. 26, 1, 4.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Microscopic Angioscopy 100%
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 96%
  • Vasculitis 68%
  • Antineutrophil Cytoplasmic Antibodies 50%
  • Granulomatosis with Polyangiitis 33%

• Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

  Hieken, T. J., Nelson, G. D., Flotte, T. J., Grewal, E. P., Chen, J., McWilliams, R. R., Kottschade, L. A., Yang, L., Domingo-Musibay, E., Dronca, R. S., Yan, Y., Markovic, S. N., Dimou, A., Montane, H. N., Erskine, C. L., Piltin, M. A., Price, D. L., Khariwala, S. S., Hui, J., Strand, C. A., & 4 othersHarrington, S. M., Suman, V. J., Dong, H. & Block, M. S., Dec 2024, In: Nature communications. 15, 1, 1430.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cobimetinib 100%
  • Vemurafenib 85%
  • atezolizumab 73%
  • Melanoma 38%
  • Lymph Node Excision 30%

• Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable

  Ailawadhi, S., Shune, L., Wong, S. W., Lin, Y., Patel, K. & Jagannath, S., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Adoptive Immunotherapy 100%
  • Chimeric Antigen Receptors 93%
  • Multiple Myeloma 75%
  • T-Lymphocytes 46%
  • Cell- and Tissue-Based Therapy 41%

• Pharmacokinetics of dacarbazine and unesbulin and CYP1A2-mediated drug interactions in patients with leiomyosarcoma

  Gao, L., Kaushik, D., Van Tine, B. A., Ingham, M. A., Attia, S., Meyer, C. F., Schwartz, G. K., Maliakal, P., Baird, J. D., Ma, J., Barrett, R., D'Silva, D., O'Keefe, K. & Kong, R., Feb 2024, In: Clinical and translational science. 17, 2, e13709.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Dacarbazine 100%
  • Peak Plasma Concentration 78%
  • Cytochrome P-450 CYP1A2 74%
  • Leiomyosarcoma 69%
  • Drug Interactions 56%

• Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

  Abdallah, N., Witzig, T. E., Kumar, S. K., Lacy, M. Q., Hayman, S. R., Dispenzieri, A., Roy, V., Gertz, M. A., Bergsagel, P. L. & Rajkumar, S. V., 2024, (Accepted/In press) In: Leukemia.

  Research output: Contribution to journal › Letter › peer-review

• Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab

  Ledenko, M., Mercado, L. & Patel, T., Mar 1 2024, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 47, 3, p. 105-109 5 p.

  Research output: Contribution to journal › Article › peer-review